Essay On Prostate Cancer

For example, age is the biggest factor. We all know that as men age and get older they run a higher chance of their prostate enlarging and developing cancer. Family history and race are also the other two big ones. If people in your immediate family have had the cancer, then you run a higher risk of contraction because you’re already genetically predisposed to getting prostate cancer. Also, African American men are more likely to be diagnosed with the cancer, with white and Hispanic men following behind. According to the CDC, from the years 1999-2013, black men had higher mortality and contraction rates than men of other races and ethnicities.1 Hormones are also a risk factor; should the male be producing a lot of testosterone could put him at risk.

Prostate Cancer is a disease in which there is an uncontrolled growth of cells that lines the ducts of the prostate gland. The abnormal cells can spread throughout the prostate and nearby organs, such as the seminal vesicles. If not caught early they can spread (metastasized) to other organs of the body through the lymph or blood stream. (“...Treatment...” 13) Prostate Cancer can be like a silent killer. Some may show signs and symptoms of this disease while others may not. Some symptoms may include frequent urination, blood in the urine or semen, delayed or slowed start of urinary stream and dribbling or leakage of urine. Diagnosis testing for Prostate Cancer are digital

Risk factors such as, family history. For example about 10% of men at a young age have had testicular cancer because they were born with an undescended testicle. Also, men with specific genetics such as the Klinefelter syndrome, Down syndrome or family that has had the disease before, could have a high risk of the cancer to develop. Not only can family history increase the risk of the disease, but also men with sexual transmitted diseases such as HIV can possibly get testicular cancer. There are usually no early symptoms of the cancer, but at least 25% do experience them. Some early symptoms include a mass or lump that is felt in the testes, it is usually painless. Even if the lump or mass is small or large, and soft or hard it is not always cancer, the mass or lump could indicate anything else. Depending on how much the cancer has spread, there are different symptoms for each. For example, if the cancer has spread beyond the testicle such as the lymph nodes in the abdomen or the lungs and brain symptoms such

It has been estimated that men who have an affected first degree relative (e.g. father or brother) and an affected second-degree relative (e.g. grandfather or uncle) have an eightfold increase in risk. It is unclear as to whether this genetic disposition has to do with actual gene defects or with similar patterns in diet and lifestyle.

Prostate cancer is considered as the most commonly diagnosed cancer in men, in the U. S and most cases of prostate cancer have a good prognosis. Some of these cases can be aggressive and the death-rate is assessed to be 2.8%. The Prostate-specific antigen (PSA) test is used for screening for prostate cancer, to aid early detection and treatment.

Prostate cancer is one of the major health concerns of the public. Worldwide prostate cancer has affected a big portion of the population and has become an issue for many males all around the world. Prostate cancer refers to the malignant growth of glandular cells located in the prostate. At the age of 85, a man is said to have a 1 in 5 chances of developing prostate cancer sometime in their life. Unfortunately Prostate cancer is a disease that does not give any warning signs when it is growing and so the clinical features of prostate are often nonspecific. Patients with prostate cancer have different types of treatment in which they can accept, there can be various methods such as surgery and theraypy toptions. There are

The most accurate way to detect cancer cells inside the prostate gland is the surgical removal and histopathological examination of the entire gland. As this approach is clinically inapplicable to each patient with suspicious findings, Transrectal ultrasound (TRUS) guided prostatic biopsy is considered the standard diagnostic procedure for the detection of prostate cancer for patients with a high suspicion for prostate cancer 1.

Prostate cancer is the second most frequently diagnosed cancer and the sixth leading cause of cancer death in males. Incidence rates vary more than 25-fold worldwide, with the highest rates in the developed countries this may be due to the widespread use of prostate-specific antigen testing and subsequent prostate biopsy in these regions [1]. Overall, the complex morphology, histologic heterogeneity, and the early signs of high malignant potential preclude a straightforward assessment of the metastatic potential of localized prostate carcinoma and show the requirement for extra clinical and pathologic tests for the evaluation of prostate carcinoma stage and clinical behavior[2]

Whether we diagnose with a disease or illness were uncontrollable and prostate cancer is one of them that does not have a treatment. However, there are ways we could found out whether we had prostate cancer or not by detecting through scanning. The early detection includes the Prostate- Specific Antigen (PSA) and Digital Recital Exam (DRE). Equally, early screening can help us to find out the abnormal size of the gland and easily to cure when we know the size. People who had prostate cancer can still live at a really high live span through early detection and taking care of the prostate cancer throughout the years. In addition, the Prostate-specific Antigen (PSA) is a scanning to see if the cells in the prostate gland and did the gland healthy or not. That size should be less than 4 nomograms per milliliters (ng/ml) in their blood to be consider healthy. However, there are a lot of reports about the Prostate-Specific Antigen is not effective and may cause harm due to the controversial surrounding of what it caused. According to a report in The Journal of the American Medical Association (JAMA), it states that “… because most prostate cancer will never cause harm, PSA screening considerably increases the risk of receiving a diagnosis of prostate cancer, leading to treatment morbidity among men, with no possibility of benefit” (Hayes, 2014). Since most of the PSA treatment were not 1000 % accurate and sometimes it may lead to fake results. Therefore, the chance of causing more harms due to the results not reliable and the report shows not a significant heal rate in the PSA treatments. So, the benefits of early screening in PSA did not help men in later age who diagnosed with prostate

Being diagnosed with cancer has always been taken as a death sentence by a majority of the population. This can partly be contributed by the fact that most people do not understand clearly what cancer is. The way most reporters and some journalist have reviewed information relating to prostate cancer has been hazardous.

An enlarged prostate (also known as benign prostatic hyperplasia) may also be responsible for the increases PSA and urinary problems. It is a common condition affecting 40% of men over 50; and it accounts for the patients urinary problems (Prostate Cancer UK, 2013b). A transurethral resection of the prostate (TURP) may be performed if BHP was suspected.

Prostate cancer is a cancer relating to the prostate, a gland located in front of the rectum and below the urinary bladder (ACS 2015). Prostate cancer only affects the male population because the prostate gland is only found in the male reproductive system (FIS 2015). Among the males in the world, certain males are at higher risk than others due to certain risk factors. One of the biggest risk factors is age (PCF 2015). Only 1 in 10000 men under the age of 40 will be diagnosed with prostate cancer however 1 in 38 men between the ages of 40 – 59 will be diagnosed (PCF 2015). This then shoots up further to 1 in 14 men among the age of 60-69 (PCF 2015). Over 65% of all prostate cancer diagnoses are in men that are over the age of 65 (PCF 2015).

Prostate cancer, what’s the big deal? It’s treatable right? So many famous people have been diagnosed and they seem to be OK, right? Plus, nobody actually dies of prostate cancer, right? Wrong. It’s estimated that over 28,000 lives will be lost this year to Prostate cancer in the U.S. alone. Let’s put this into perspective: people always say flying is a safe way to travel causing only 469 deaths per year. This is especially true in comparison to driving which causes 35,080 deaths per year. In most recent statistics, number of men who died of prostate cancer was nearly the same as number of people who died in driving accidents, with 32,050 deaths. That’s 32,050 fathers, sons, brothers and uncles that won’t be around for our birthdays, Christmas, Thanksgiving, everyday events and much more.

This growth causes squeezing of the urethra, which then leads to urinary problems. Doctors are not clear about what causes the prostate to enlarge, but hormonal changes brought about by age are believed to be the leading cause. Family history, obesity, diabetes and heart diseases are some of the risk factors for prostate enlargement, as well as age and ethnicity (Asian men are less likely to develop BPH than white and black men).

Boyter was proposed a variety of options regarding how best to treat his cancer. His biopsy and PSA level indicated that he had low risk of disease. These characteristics are helpful, but often are not reflective of the extent of the tumor within the prostate. Thus, a physician cannot fully determine whether a patient has low risk prostate cancer that can be managed with active surveillance (AS), a clinically acceptable course of conservative management for men with low risk cancers, or whether he has aggressive prostate cancer and would benefit from surgery or radiation therapy without the results of an Oncotype DX Prostate Cancer Assay, he and his physician did not have a complete understanding of the biology of his